Dr Belinda Hii

Dr Belinda Hii MBBS FRACS Consultant Endocrine Surgeon

Belinda recently returned to Melbourne after completing subspecialty training in endocrine surgery. She completed surgical training through the Alfred Health network and was admitted as a Fellow of the Royal Australasian College of Surgeons (FRACS) in General Surgery in 2019.

She undertook her first fellowship in endocrine and general surgery at Footscray Hospital. Following this, She was appointed the Selwyn Taylor Fellow in Endocrine Surgery at the Hammersmith Hospital in London – a highly competitive position at one of the highest volume endocrinology and endocrine surgery referral centres in the UK. Here, she trained with Professor Fausto Palazzo, Professor Neil Tolley and Ms Aimee DiMarco in all areas of endocrine surgery gaining invaluable experience in minimally invasive adrenal surgery, parathyroidectomy for secondary and tertiary
hyperparathyroidism and multigland disease and re-operative thyroid and parathyroid surgery. She is trained in the use of IoPTH and both camera and probe based parathyroid autofluorescence techniques. She has travelled to Germany to train with Professor Martin Walz – the surgeon who described and developed the retroperitoneoscopic adrenalectomy. She has also co-authored a chapter on cervical lymphadenopathy in PTC.She was an invited speaker at the BAETS meeting in London 2024. Outside of medicine she enjoys skiing, running and being bossed around by her two wonderful children.

She is available for private consultations in Frankston and East Melbourne, and is accredited privately at Epworth Freemasons and Peninsula Private Hospitals. She would value the opportunity to work with you in proving excellent endocrine surgical care.

Current waiting times

• Outpatient referral – 4 weeks
• Operative wait list – 4-6 weeks

Special Interests

• Minimally invasive adrenal surgery
• both retroperitoneoscopic and laparoscopic approaches

Parathyroidectomy

• Minimally invasive parathyroidectomy
• Neck exploration for non-localised disease
• Subtotal parathyroidectomy for renal hyperparathyroidism

MEN 1 and Lithium induced hyperparathyroidism

Thyroidectomy

Cervical lymphadenopathy for thyroid cancer